|  Help  |  About  |  Contact Us

Publication : Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice.

First Author  Wong JK Year  2015
Journal  PLoS One Volume  10
Issue  8 Pages  e0136967
PubMed ID  26317208 Mgi Jnum  J:243023
Mgi Id  MGI:5907431 Doi  10.1371/journal.pone.0136967
Citation  Wong JK, et al. (2015) Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice. PLoS One 10(8):e0136967
abstractText  Stroke results in brain tissue damage from ischemia and oxidative stress. Molecular regulators of the protective versus deleterious cellular responses after cerebral ischemia remain to be identified. Here, we show that deletion of Smad1, a conserved transcription factor that mediates canonical bone morphogenetic protein (BMP) signaling, results in neuroprotection in an ischemia-reperfusion (I/R) stroke model. Uninjured mice with conditional deletion of Smad1 in the CNS (Smad1 cKO) displayed upregulation of the reactive astrocyte marker GFAP and hypertrophic morphological changes in astrocytes compared to littermate controls. Additionally, cultured Smad1(-/-) astrocytes exhibited an enhanced antioxidant capacity. When subjected to I/R injury by transient middle cerebral artery occlusion (tMCAO), Smad1 cKO mice showed enhanced neuronal survival and improved neurological recovery at 7 days post-stroke. This neuroprotective phenotype is associated with attenuated reactive astrocytosis and neuroinflammation, along with reductions in oxidative stress, p53 induction, and apoptosis. Our data suggest that Smad1-mediated signaling pathway is involved in stroke pathophysiology and may present a new potential target for stroke therapy.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression